Medios AI

The Medios AI is a clinically validated, Artificial Intelligence software running on the Remidio Non-Mydriatic Fundus On Phone. It automatically detects Referable Diabetic Retinopathy (RDR) lesions in captured images, thus enabling instant reporting for RDR, in non-specialist contexts.

* Please validate local regulatory requirements for use of Artificial Intelligence Software.





Simple to Use

The software runs directly on the smartphone of the Remidio Non Mydriatic-Fundus On Phone without requiring internet connectivity. Generating a report for diabetic retinopathy requires only a few additional clicks after image capture, and is done in just 15 seconds for two images. The software also detects images of insufficient quality and requests the operator to recapture, when required.

Insightful Reports

The algorithm has been designed to maximize sensitivity for Referable DR and specificity for any DR. It automatically detects presence of RDR. It also highlights areas with possible pathologies in the retina, providing support in patient education, as well.

Clinically Validated

The Medios AI has been prospectively validated in several studies. The sensitivity was 100% for Referable DR and the specificity was 92% for No DR, in a prospective, opportunistic screening trial on 250 diabetic patients.